Omnicell wraps up Ateb acquisition

Print Friendly, PDF & Email

MOUNTAIN VIEW, Calif. — Omnicell Inc. has closed its $41 million deal to acquire pharmacy patient care and medication synchronization specialist Ateb Inc.

pharmacy sign_from BartellOmnicell and Ateb announced the agreement late last month. Omnicell said Wednesday that uniting its SureMed medication adherence packaging and related automation with Ateb’s patient engagement platform will enable it to better support pharmacists as they deploy and scale their medication compliance programs.

Tackling medication nonadherence — estimated to result in avoidable health care costs of more than $105 billion in the United States — has been a priority for pharmacists as they work to improve patient health outcomes in retail settings.

“By understanding the clinical and fiscal challenges these providers face, Omnicell now offers a portfolio of products and services that address the need for improved adherence across the continuum of care. We are excited about the strong potential of the combined entity and to continue our mission of improving adherence and patient outcomes,” stated Troy Hilsenroth, vice president and general manager of medication adherence at Omnicell.

Based in Mountain View, Calif., Omnicell is a provider of medication and supply management solutions and adherence tools to health care systems and pharmacies. Raleigh, N.C.-based Ateb, known for its Time My Meds med sync solution and Patient Management Access Portal, totaled sales of about $27 million for the 12 months ended Sept. 30.



Comments are closed.